103 results
Page 5 of 6
8-K
EX-4.1
34rq 2t4ga7njt3
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
424B5
3mxe176lblb7ch28lh
8 Apr 19
Prospectus supplement for primary offering
12:00am
424B5
hlh4lzjs
4 Apr 19
Prospectus supplement for primary offering
4:15pm
424B5
g3yvp q46
4 Apr 19
Prospectus supplement for primary offering
4:13pm
8-K
EX-10.1
jdeahz1yudv d1pk3
11 Jan 19
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-99.2
9kwedcw
7 Jan 19
Regulation FD Disclosure
6:30am
8-K
EX-99.1
w3o6yy8xr l927dktkm2
3 Dec 18
Syros Announces Promising Clinical Data from Ongoing Phase 2 Trial of SY-1425 in Genomically Defined AML and MDS Patients at ASH Annual Meeting
8:07am
8-K
EX-99.2
xsnhfkbnfa 2c
15 Nov 18
Regulation FD Disclosure
4:03pm
8-K
EX-99.1
1mga7
15 Nov 18
Regulation FD Disclosure
4:03pm